Search Prime Grants

U41HG000739

Cooperative Agreement

Overview

Grant Description
FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE
Funding Goals
NHGRI SUPPORTS THE DEVELOPMENT OF RESOURCES AND TECHNOLOGIES THAT WILL ACCELERATE GENOME RESEARCH AND ITS APPLICATION TO HUMAN HEALTH AND GENOMIC MEDICINE. A CRITICAL PART OF THE NHGRI MISSION CONTINUES TO BE THE STUDY OF THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) OF GENOME RESEARCH. NHGRI ALSO SUPPORTS THE TRAINING AND CAREER DEVELOPMENT OF INVESTIGATORS AND THE DISSEMINATION OF GENOME INFORMATION TO THE PUBLIC AND TO HEALTH PROFESSIONALS. THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM IS USED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM IS USED TO FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Place of Performance
Cambridge, Massachusetts 021382020 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the End Date has been extended from 03/31/18 to 03/31/24 and the total obligations have increased 881% from $3,279,871 to $32,186,204.
President And Fellows Of Harvard College was awarded FLYBASE: A DROSOPHILA GENOMIC AND GENETIC DATABASE Cooperative Agreement U41HG000739 worth $32,186,204 from National Human Genome Research Institute in August 1992 with work to be completed primarily in Cambridge Massachusetts United States. The grant has a duration of 31 years 7 months and was awarded through assistance program 93.172 Human Genome Research. The Cooperative Agreement was awarded through grant opportunity Genomic Resource Grants for Community Resource Projects (U41).

Status
(Complete)

Last Modified 10/21/24

Period of Performance
8/1/92
Start Date
3/31/24
End Date
100% Complete

Funding Split
$32.2M
Federal Obligation
$0.0
Non-Federal Obligation
$32.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U41HG000739

Subgrant Awards

Disclosed subgrants for U41HG000739

Transaction History

Modifications to U41HG000739

Additional Detail

Award ID FAIN
U41HG000739
SAI Number
U41HG000739-2518680971
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N400 NIH NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Funding Office
75N400 NIH NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Awardee UEI
LN53LCFJFL45
Awardee CAGE
1NQH4
Performance District
MA-05
Senators
Edward Markey
Elizabeth Warren

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Human Genome Research Institute, National Institutes of Health, Health and Human Services (075-0891) Health research and training Grants, subsidies, and contributions (41.0) $28,804,296 100%
Modified: 10/21/24